We came across a bullish thesis on Mereo BioPharma Group plc (MREO) on Substack by Jake LaMotta. In this article, we will summarize the bulls’ thesis on MREO. Mereo BioPharma Group plc (MREO)'s share was trading at $2 as of April 16th.
[caption id="attachment_1238904" align="aligncenter" width="768"]Mereo BioPharma (MREO) appears to be one of the most mispriced biotech opportunities following the broader XBI sell-off, trading at $1.80 despite prior enthusiasm...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.